Good Progress But Challenges Remain For Japan’s AMED
This article was originally published in PharmAsia News
Executive Summary
Japan's year-old AMED is "now looking at how to expand its budget" and seeking new routes of cooperation, as it aims to foster better coordinated basic medical research between industry, academia and public institutes in the country.